Dirk M. van der Steen

1.0k total citations
28 papers, 747 citations indexed

About

Dirk M. van der Steen is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Dirk M. van der Steen has authored 28 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 18 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Dirk M. van der Steen's work include CAR-T cell therapy research (18 papers), Immunotherapy and Immune Responses (15 papers) and Immune Cell Function and Interaction (9 papers). Dirk M. van der Steen is often cited by papers focused on CAR-T cell therapy research (18 papers), Immunotherapy and Immune Responses (15 papers) and Immune Cell Function and Interaction (9 papers). Dirk M. van der Steen collaborates with scholars based in Netherlands, United States and United Kingdom. Dirk M. van der Steen's co-authors include Mirjam H.M. Heemskerk, Renate S. Hagedoorn, J.H. Frederik Falkenburg, Peter A. van Veelen, Arnoud H. de Ru, Michel G.D. Kester, Marieke Griffioen, Inge Jedema, Avital L. Amir and Anne K. Wouters and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Dirk M. van der Steen

28 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk M. van der Steen Netherlands 14 440 432 283 145 109 28 747
E Aruga United States 8 283 0.6× 484 1.1× 231 0.8× 80 0.6× 34 0.3× 9 646
Elena Sadovnikova United Kingdom 10 426 1.0× 557 1.3× 188 0.7× 180 1.2× 83 0.8× 19 810
Mehmet H. Kocoglu United States 15 605 1.4× 243 0.6× 392 1.4× 60 0.4× 455 4.2× 60 996
Linda Pan United States 11 522 1.2× 895 2.1× 444 1.6× 106 0.7× 21 0.2× 23 1.1k
Monika Laumer Germany 8 414 0.9× 596 1.4× 116 0.4× 94 0.6× 34 0.3× 9 714
Gitta Anne Heinz Germany 13 109 0.2× 416 1.0× 475 1.7× 61 0.4× 54 0.5× 27 962
Caroline Boudousquié Switzerland 12 409 0.9× 715 1.7× 361 1.3× 41 0.3× 14 0.1× 17 1.1k
Jamie P. Nourse Australia 16 479 1.1× 286 0.7× 274 1.0× 44 0.3× 55 0.5× 36 959
Matthias Zeis Germany 16 314 0.7× 634 1.5× 229 0.8× 51 0.4× 368 3.4× 42 931
Christelle Harly United States 18 431 1.0× 1.5k 3.4× 305 1.1× 44 0.3× 59 0.5× 28 1.7k

Countries citing papers authored by Dirk M. van der Steen

Since Specialization
Citations

This map shows the geographic impact of Dirk M. van der Steen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk M. van der Steen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk M. van der Steen more than expected).

Fields of papers citing papers by Dirk M. van der Steen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk M. van der Steen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk M. van der Steen. The network helps show where Dirk M. van der Steen may publish in the future.

Co-authorship network of co-authors of Dirk M. van der Steen

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk M. van der Steen. A scholar is included among the top collaborators of Dirk M. van der Steen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk M. van der Steen. Dirk M. van der Steen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wouters, Anne K., Renate S. Hagedoorn, Michel G.D. Kester, et al.. (2023). Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain. Journal of Hematology & Oncology. 16(1). 16–16. 9 indexed citations
2.
Wouters, Anne K., Marian van de Meent, Dennis F.G. Remst, et al.. (2023). PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer. Frontiers in Immunology. 14. 1121973–1121973. 16 indexed citations
3.
Wouters, Anne K., Renate S. Hagedoorn, Michel G.D. Kester, et al.. (2022). Cutting Edge: Unconventional CD8+ T Cell Recognition of a Naturally Occurring HLA-A*02:01–Restricted 20mer Epitope. The Journal of Immunology. 208(8). 1851–1856. 3 indexed citations
4.
Hagedoorn, Renate S., Dennis F.G. Remst, Dirk M. van der Steen, et al.. (2022). WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma. Journal for ImmunoTherapy of Cancer. 10(6). e004409–e004409. 17 indexed citations
5.
Remst, Dennis F.G., Dirk M. van der Steen, Anne K. Wouters, et al.. (2022). A library of cancer testis specific T cell receptors for T cell receptor gene therapy. Molecular Therapy — Oncolytics. 28. 1–14. 11 indexed citations
6.
Wouters, Anne K., Lorenz Jahn, Renate S. Hagedoorn, et al.. (2021). A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapy. Molecular Therapy. 30(2). 564–578. 9 indexed citations
7.
Steen, Dirk M. van der, Marlieke L.M. Jongsma, Arnoud H. de Ru, et al.. (2021). Healthy cells functionally present TAP-independent SSR1 peptides: implications for selection of clinically relevant antigens. iScience. 24(2). 102051–102051. 3 indexed citations
8.
Reijmers, Rogier M., Renate S. Hagedoorn, Rob C. M. de Jong, et al.. (2019). Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia. Journal of Clinical Investigation. 129(2). 774–785. 127 indexed citations
9.
Hagedoorn, Renate S., Michel G.D. Kester, Dirk M. van der Steen, et al.. (2017). Mutated NPM1 As Target for Immunotherapy of Acute Myeloid Leukemia. Blood. 130. 168–168. 1 indexed citations
10.
Gezgin, Gülçin, Jinfeng Cao, Mehmet Doğrusöz, et al.. (2017). PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma. JAMA Ophthalmology. 135(6). 541–541. 86 indexed citations
11.
Spel, Lotte, Jaap Jan Boelens, Dirk M. van der Steen, et al.. (2015). Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma. Oncotarget. 6(34). 35770–35781. 39 indexed citations
12.
Jahn, Lorenz, Renate S. Hagedoorn, Pleun Hombrink, et al.. (2015). T Cell Receptor Gene Therapy Targeting the Intracellular Transcription Factor Bob1 for the Treatment of Multiple Myeloma and Other B Cell Malignancies. Blood. 126(23). 3002–3002. 1 indexed citations
13.
Breman, Eytan, Dirk M. van der Steen, Mirjam H.M. Heemskerk, et al.. (2014). HLA Monomers as a Tool to Monitor Indirect Allorecognition. Transplantation. 97(11). 1119–1127. 10 indexed citations
14.
Jahn, Lorenz, Pleun Hombrink, Michel G.D. Kester, et al.. (2014). T Cell Receptors Specific for the Intracellular Transcription Factor Bob1 Allow Efficient Targeting of Human B Cell Leukemia and Multiple Myeloma. Blood. 124(21). 3832–3832. 1 indexed citations
15.
Jahn, Lorenz, Pleun Hombrink, Cesare Hassan, et al.. (2014). Therapeutic targeting of the BCR-associated protein CD79b in a TCR-based approach is hampered by aberrant expression of CD79b. Blood. 125(6). 949–958. 17 indexed citations
16.
Amir, Avital L., Dirk M. van der Steen, Marleen M. van Loenen, et al.. (2011). PRAME-Specific Allo-HLA–Restricted T Cells with Potent Antitumor Reactivity Useful for Therapeutic T-Cell Receptor Gene Transfer. Clinical Cancer Research. 17(17). 5615–5625. 92 indexed citations
17.
Zandvliet, Maarten L., J.H. Frederik Falkenburg, Ellis van Liempt, et al.. (2010). Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection. Haematologica. 95(11). 1943–1951. 54 indexed citations
18.
Zandvliet, Maarten L., Ellis van Liempt, Louise A. Veltrop‐Duits, et al.. (2010). Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection Running head: M. Zandvliet et al. HAdV-specific T cells after alloSCT. 2 indexed citations
19.
Heiden, Pim L. J. van der, Renate de Boer, Dirk M. van der Steen, et al.. (2009). Identification of Varicella-Zoster Virus-Specific CD8 T Cells in Patients after T-Cell-Depleted Allogeneic Stem Cell Transplantation. Journal of Virology. 83(14). 7361–7364. 13 indexed citations
20.
Louwerse, Jeanine, et al.. (2007). Stable Recombinase-Mediated Cassette Exchange in Arabidopsis UsingAgrobacterium tumefaciens . PLANT PHYSIOLOGY. 145(4). 1282–1293. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026